ICD-10: I26.93

Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale

Clinical Information

Inclusion Terms

  • Subsegmental pulmonary embolism NOS

Additional Information

Description

ICD-10 code I26.93 refers to a specific diagnosis of single subsegmental thrombotic pulmonary embolism without acute cor pulmonale. This condition is a type of pulmonary embolism (PE), which occurs when a blood clot (thrombus) obstructs a pulmonary artery or one of its branches, leading to impaired blood flow to the lungs. Below is a detailed clinical description and relevant information regarding this diagnosis.

Clinical Description

Definition

Single subsegmental thrombotic pulmonary embolism is characterized by the presence of a thrombus located in a subsegmental pulmonary artery. Subsegmental arteries are smaller branches of the pulmonary arteries that supply blood to specific areas of the lung. The term "single" indicates that only one such thrombus is present.

Pathophysiology

Pulmonary embolism typically arises from deep vein thrombosis (DVT), where a clot forms in the deep veins of the legs or other parts of the body and travels to the lungs. In the case of a subsegmental PE, the clot is smaller and may not cause significant obstruction of blood flow compared to larger emboli. However, it can still lead to symptoms and complications, particularly if it affects lung function.

Symptoms

Patients with a single subsegmental pulmonary embolism may present with a variety of symptoms, which can range from mild to severe. Common symptoms include:
- Shortness of breath: This may occur suddenly or gradually.
- Chest pain: Often sharp and may worsen with deep breathing or coughing.
- Cough: Sometimes accompanied by hemoptysis (coughing up blood).
- Rapid heart rate: Tachycardia may be present as the body attempts to compensate for reduced oxygenation.

Diagnosis

Diagnosis of a single subsegmental PE typically involves:
- Imaging studies: A CT pulmonary angiography (CTPA) is the gold standard for visualizing pulmonary emboli. It can identify the location and extent of the thrombus.
- D-dimer test: Elevated levels of D-dimer can indicate the presence of a thrombus, although this test is not specific to PE.
- Ultrasound: This may be used to detect DVT in the legs, which can be a source of the embolism.

Management

Management of a single subsegmental pulmonary embolism may include:
- Anticoagulation therapy: The primary treatment involves the use of anticoagulants (e.g., heparin, warfarin, or direct oral anticoagulants) to prevent further clot formation and allow the body to dissolve the existing clot.
- Monitoring: Patients may require close monitoring for any signs of deterioration or complications.
- Supportive care: This may include oxygen therapy if the patient is hypoxic.

Without Acute Cor Pulmonale

The specification "without acute cor pulmonale" indicates that the patient does not exhibit signs of acute right heart failure, which can occur when there is significant strain on the right side of the heart due to increased pressure in the pulmonary arteries. This distinction is important for treatment and prognosis, as the presence of cor pulmonale can complicate the clinical picture and management strategies.

Conclusion

ICD-10 code I26.93 captures a specific and clinically significant condition of single subsegmental thrombotic pulmonary embolism without acute cor pulmonale. Understanding this diagnosis is crucial for healthcare providers in order to implement appropriate diagnostic and therapeutic strategies, ensuring optimal patient outcomes. Early recognition and treatment of pulmonary embolism are vital to prevent complications and improve survival rates.

Clinical Information

Clinical Presentation of Single Subsegmental Thrombotic Pulmonary Embolism (ICD-10 Code I26.93)

Single subsegmental thrombotic pulmonary embolism (PE) is a specific type of pulmonary embolism characterized by the obstruction of a single subsegmental pulmonary artery by a thrombus. This condition can present with a variety of clinical signs and symptoms, and understanding these can aid in timely diagnosis and management.

Signs and Symptoms

  1. Dyspnea (Shortness of Breath):
    - One of the most common symptoms, dyspnea may occur suddenly and can range from mild to severe. Patients often report difficulty breathing, especially during exertion[1].

  2. Chest Pain:
    - Patients may experience pleuritic chest pain, which is sharp and worsens with deep breathing or coughing. This pain can mimic that of a myocardial infarction or other cardiac conditions[2].

  3. Cough:
    - A dry cough may be present, and in some cases, it can be associated with hemoptysis (coughing up blood), although this is less common in subsegmental PE compared to larger emboli[3].

  4. Tachycardia:
    - An increased heart rate is often observed, which can be a compensatory response to decreased oxygenation or increased workload on the heart[4].

  5. Hypoxemia:
    - Patients may exhibit low oxygen saturation levels, which can be assessed using pulse oximetry. This is indicative of impaired gas exchange due to the obstruction of blood flow in the lungs[5].

  6. Anxiety:
    - Many patients report feelings of anxiety or a sense of impending doom, which can be attributed to the acute nature of the symptoms and the body's response to hypoxia[6].

Patient Characteristics

  1. Risk Factors:
    - Patients with a history of venous thromboembolism, recent surgery (especially orthopedic or pelvic), prolonged immobility, or malignancy are at higher risk for developing subsegmental PE. Other risk factors include obesity, smoking, and certain genetic predispositions[7].

  2. Demographics:
    - While PE can affect individuals of any age, it is more commonly diagnosed in adults, particularly those over 50 years old. Gender differences may also be noted, with some studies indicating a higher prevalence in males[8].

  3. Comorbid Conditions:
    - Patients with underlying conditions such as chronic obstructive pulmonary disease (COPD), heart failure, or other cardiovascular diseases may present with more pronounced symptoms and complications[9].

  4. Clinical Presentation Variability:
    - The clinical presentation can vary significantly among patients. Some may be asymptomatic or present with mild symptoms, while others may exhibit severe respiratory distress. This variability can complicate diagnosis, as subsegmental PE may not always be detected on standard imaging studies[10].

Diagnostic Considerations

  • Imaging:
  • Computed tomography pulmonary angiography (CTPA) is the gold standard for diagnosing pulmonary embolism, including subsegmental types. However, in cases where CTPA is inconclusive, alternative imaging modalities such as ventilation-perfusion (V/Q) scans may be utilized[11].

  • D-dimer Testing:

  • Elevated D-dimer levels can indicate the presence of thrombus but are not specific to PE. This test is often used in conjunction with clinical assessment to rule out PE in low-risk patients[12].

Conclusion

Single subsegmental thrombotic pulmonary embolism (ICD-10 code I26.93) presents a unique challenge in clinical practice due to its often subtle symptoms and the variability in patient presentation. Recognizing the signs and symptoms, understanding patient characteristics, and employing appropriate diagnostic tools are crucial for effective management. Early identification and treatment can significantly improve patient outcomes and reduce the risk of complications associated with pulmonary embolism.

Approximate Synonyms

The ICD-10 code I26.93 refers specifically to "Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale." This code is part of the broader category of pulmonary embolism codes, which are used to classify various types of pulmonary embolism based on their characteristics and clinical implications. Below are alternative names and related terms associated with I26.93.

Alternative Names

  1. Single Subsegmental Pulmonary Embolism: This term emphasizes the specific location of the embolism within the pulmonary vasculature, indicating that it is confined to a single subsegmental artery.

  2. Thrombotic Pulmonary Embolism: This phrase highlights the thrombotic nature of the embolism, indicating that it is caused by a blood clot.

  3. Non-Acute Cor Pulmonale Pulmonary Embolism: This term specifies that the embolism is not associated with acute cor pulmonale, a condition characterized by right heart failure due to pulmonary hypertension.

  1. Pulmonary Embolism (PE): A general term for the blockage of a pulmonary artery by a blood clot, which can vary in size and location.

  2. Subsegmental Pulmonary Embolism: Refers to embolisms that occur in the subsegmental arteries of the lungs, which are smaller branches of the pulmonary arteries.

  3. Thromboembolism: A broader term that encompasses any blockage caused by a thrombus (blood clot) that has traveled from another part of the body.

  4. Chronic Pulmonary Embolism: While I26.93 refers to a specific acute condition, chronic pulmonary embolism can occur when there are recurrent embolisms leading to long-term complications.

  5. Vascular Occlusion: A general term that can refer to any blockage in the vascular system, including those caused by embolisms.

  6. Deep Vein Thrombosis (DVT): Often related to pulmonary embolism, DVT refers to blood clots that form in the deep veins, typically in the legs, which can dislodge and travel to the lungs.

Clinical Context

Understanding these alternative names and related terms is crucial for healthcare professionals involved in coding, billing, and treatment planning. Accurate coding ensures proper documentation and reimbursement, while also facilitating effective communication among healthcare providers regarding patient conditions.

In summary, the ICD-10 code I26.93 is associated with various terms that describe the nature and implications of the condition it represents. Familiarity with these terms can enhance clarity in clinical discussions and documentation practices.

Diagnostic Criteria

The diagnosis of ICD-10 code I26.93, which refers to single subsegmental thrombotic pulmonary embolism without acute cor pulmonale, involves specific clinical criteria and diagnostic processes. Understanding these criteria is essential for accurate coding and effective patient management.

Overview of Pulmonary Embolism

Pulmonary embolism (PE) occurs when a blood clot (thrombus) travels to the lungs, blocking a pulmonary artery. A subsegmental pulmonary embolism is a type of PE that affects the smaller branches of the pulmonary arteries, specifically those that are smaller than segmental arteries. The absence of acute cor pulmonale indicates that there is no acute right heart failure associated with the embolism at the time of diagnosis.

Diagnostic Criteria

Clinical Presentation

  1. Symptoms: Patients may present with symptoms such as:
    - Sudden onset of shortness of breath
    - Chest pain, which may be pleuritic (worsening with deep breaths)
    - Cough, which may be accompanied by hemoptysis (coughing up blood)
    - Tachycardia (rapid heart rate) and tachypnea (rapid breathing)

  2. Risk Factors: A thorough assessment of risk factors is crucial. These may include:
    - Recent surgery or prolonged immobility
    - History of deep vein thrombosis (DVT)
    - Cancer or active malignancy
    - Hormonal therapy or pregnancy
    - Genetic predispositions to clotting disorders

Diagnostic Imaging

  1. CT Pulmonary Angiography (CTPA): This is the gold standard for diagnosing pulmonary embolism. A CTPA can visualize the pulmonary arteries and identify the presence of clots, including subsegmental emboli.

  2. Ventilation-Perfusion (V/Q) Scan: In cases where CTPA is contraindicated (e.g., renal insufficiency), a V/Q scan may be used. A mismatch between ventilation and perfusion can indicate the presence of a pulmonary embolism.

  3. Ultrasound: Doppler ultrasound of the legs may be performed to identify DVT, which can be a source of emboli.

Laboratory Tests

  1. D-dimer Test: Elevated levels of D-dimer can suggest the presence of an abnormal clotting process. However, this test is not specific and is often used in conjunction with imaging studies.

  2. Arterial Blood Gas (ABG): This test may show hypoxemia (low oxygen levels) and respiratory alkalosis, which can occur in PE.

Exclusion of Other Conditions

It is essential to rule out other potential causes of the symptoms, such as:
- Myocardial infarction
- Pneumonia
- Aortic dissection
- Other pulmonary conditions

Conclusion

The diagnosis of ICD-10 code I26.93 requires a combination of clinical evaluation, imaging studies, and laboratory tests to confirm the presence of a single subsegmental thrombotic pulmonary embolism without acute cor pulmonale. Accurate diagnosis is critical for appropriate management and treatment, which may include anticoagulation therapy and monitoring for potential complications. Understanding these criteria not only aids in proper coding but also enhances patient care by ensuring timely and effective intervention.

Treatment Guidelines

Overview of Single Subsegmental Thrombotic Pulmonary Embolism (I26.93)

Single subsegmental thrombotic pulmonary embolism (PE) is a specific type of pulmonary embolism characterized by the obstruction of a single subsegmental pulmonary artery by a thrombus (blood clot). The ICD-10 code I26.93 refers to this condition without the presence of acute cor pulmonale, which is a complication that can arise from severe pulmonary hypertension due to PE. Understanding the standard treatment approaches for this condition is crucial for effective management and patient outcomes.

Standard Treatment Approaches

1. Anticoagulation Therapy

The cornerstone of treatment for pulmonary embolism, including single subsegmental thrombotic PE, is anticoagulation therapy. This approach aims to prevent further clot formation and allow the body to gradually dissolve the existing clot. The following anticoagulants are commonly used:

  • Low Molecular Weight Heparin (LMWH): Agents such as enoxaparin are often the first line of treatment due to their ease of use and predictable pharmacokinetics.
  • Unfractionated Heparin (UFH): This may be used in cases requiring rapid anticoagulation, particularly in hospitalized patients.
  • Direct Oral Anticoagulants (DOACs): Medications like rivaroxaban and apixaban are increasingly used for outpatient management due to their convenience and reduced need for monitoring compared to traditional anticoagulants.

The duration of anticoagulation therapy typically ranges from three months to longer, depending on the underlying risk factors for thromboembolism and the patient's clinical situation[1][2].

2. Thrombolytic Therapy

Thrombolytic therapy, which involves the administration of drugs to dissolve clots, is generally reserved for patients with more severe forms of PE or those who present with hemodynamic instability. For patients with single subsegmental PE who are stable and without significant symptoms, thrombolytics are not typically indicated due to the lower risk of complications compared to larger emboli[3].

3. Inferior Vena Cava (IVC) Filters

In certain cases, particularly for patients who have recurrent PE despite adequate anticoagulation or those who cannot tolerate anticoagulants, an inferior vena cava filter may be considered. This device is placed in the IVC to prevent clots from traveling to the lungs. However, the use of IVC filters is more common in patients with extensive thromboembolic disease rather than isolated subsegmental PE[4].

4. Supportive Care

Supportive care is essential in managing symptoms and improving patient comfort. This may include:

  • Oxygen Therapy: To address hypoxemia, supplemental oxygen may be provided.
  • Pain Management: Analgesics can be administered to relieve chest pain associated with PE.
  • Monitoring: Continuous monitoring of vital signs and oxygen saturation is crucial, especially in the acute setting.

Follow-Up and Long-Term Management

After initial treatment, follow-up is important to assess the resolution of the embolism and to manage any underlying risk factors. Patients may require:

  • Regular Imaging: Follow-up imaging studies, such as CT pulmonary angiography, may be performed to evaluate the status of the embolism.
  • Assessment of Risk Factors: Identifying and managing risk factors for venous thromboembolism (VTE), such as obesity, immobility, or genetic predispositions, is critical for preventing recurrence[5].

Conclusion

The management of single subsegmental thrombotic pulmonary embolism (ICD-10 code I26.93) primarily involves anticoagulation therapy, with additional options like thrombolytics and IVC filters considered based on individual patient circumstances. Supportive care and long-term follow-up are essential components of a comprehensive treatment plan. By adhering to these standard approaches, healthcare providers can effectively manage this condition and reduce the risk of complications.

For further information or specific case management strategies, consulting with a specialist in pulmonary medicine or hematology may be beneficial.

Related Information

Description

  • Pulmonary artery thrombus obstruction
  • Smaller clot than typical PE
  • No acute right heart failure
  • Single subsegmental location
  • Thrombus in smaller pulmonary arteries
  • Impaired lung blood flow and function
  • Requires anticoagulation therapy

Clinical Information

  • Dyspnea (Shortness of Breath)
  • Chest Pain (Pleuritic and Sharp)
  • Cough (Dry or Hemoptysis)
  • Tachycardia (Increased Heart Rate)
  • Hypoxemia (Low Oxygen Saturation Levels)
  • Anxiety (Impending Doom Feeling)
  • Risk Factors (Venous Thromboembolism, Surgery, Immobility)
  • Demographics (Adults over 50 Years Old)
  • Comorbid Conditions (COPD, Heart Failure, Cardiovascular Diseases)

Approximate Synonyms

  • Single Subsegmental Pulmonary Embolism
  • Thrombotic Pulmonary Embolism
  • Non-Acute Cor Pulmonale Pulmonary Embolism
  • Pulmonary Embolism (PE)
  • Subsegmental Pulmonary Embolism
  • Thromboembolism
  • Chronic Pulmonary Embolism
  • Vascular Occlusion
  • Deep Vein Thrombosis (DVT)

Diagnostic Criteria

Treatment Guidelines

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.